Antiplatelet drugs in secondary stroke prevention

被引：0

作者：

Belousov, YB ^{[1
]}

机构：

[1] Russian State Med Univ, Dept Clin Pharmacol, Moscow 117437, Russia

来源：

ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2003年

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：88 / 89

页数：2

共 50 条

[21] Secondary Stroke Prevention, and the Role of Antiplatelet Therapies
Kirshner, Howard S.
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 601 - 612
[22] Antiplatelet agents for secondary prevention of ischemic stroke
Majid, A
Delanty, N
Kantor, J
ANNALS OF PHARMACOTHERAPY, 2001, 35 (10) : 1241 - 1247
[23] Controversies in antiplatelet therapy in the secondary prevention of stroke
Adamek, T.
EUROPEAN GERIATRIC MEDICINE, 2016, 7 (01) : 65 - 69
[24] Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
Pace, Wilson D.
Earl, Ali
Bryant, Casey
Hansen, Cory
US PHARMACIST, 2020, 45 (01) : HS8 - HS12
[25] Secondary stroke prevention—personalized antiplatelet therapy
David Tanne
Nature Reviews Neurology, 2012, 8 : 536 - 537
[26] Secondary stroke prevention and antiplatelet therapy - Reply
Gebel, JM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (12) : 2568 - 2570
[27] Antiplatelet Strategies for Secondary Prevention of Stroke and TIA
Koto Ishida
Steven R. Messé
Current Atherosclerosis Reports, 2014, 16
[28] Antiplatelet medications in the secondary prevention of ischemic stroke
James D. Fleck
Current Neurology and Neuroscience Reports, 2005, 5 (1) : 1 - 3
[29] STROKE Secondary stroke prevention-personalized antiplatelet therapy
Tanne, David
NATURE REVIEWS NEUROLOGY, 2012, 8 (10) : 536 - 537
[30] Use of antiplatelet drugs in stroke prevention: time for a rethink?
Loke, Yoon K.
White, James R.
Bettencourt-Silva, Joao H.
Potter, John F.
Myint, Phyo K.
POSTGRADUATE MEDICAL JOURNAL, 2013, 89 (1052) : 309 - 310

← 1 2 3 4 5 →